High Absorption CoQ10 400 mg with BioPerine

High Absorption CoQ10 400 mg with BioPerine

Doctor's Best4.8 (3,514 ratings)
Format:Capsule Quantity: 180 Veggie Cap(s) · 180 servings
Goals
$81.99 $0.45 per serving

Product analysis

75 out of 100

High Absorption CoQ10 400 mg with BioPerine pairs clearly identified CoQ10 and black pepper ingredients in a focused formula. The CoQ10 comparison indicates good value for the amount provided.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

Both ingredients have named forms, making the formula easier to identify. Their relative absorption or quality cannot be confirmed from the available information.

Ingredient Transparency100

Both ingredient amounts and forms are disclosed. That makes comparisons with similar supplements straightforward.

Value For Money88

The CoQ10 provides good value for the amount included. Black pepper value cannot be judged separately.

Customer Satisfaction90

Customer feedback is very positive across a large review base. That supports confidence in customer satisfaction without proving the absorption claim.

Product Focus78

CoQ10 and black pepper create a focused combination. Its alignment with the intended uses appears encouraging.

Format
Capsule
Container
180 Veggie Cap(s)
Per serving
$0.45
Customer rating
4.8 · 3,514 ratings
Report analysis

Goals

Energy
Impact
Highest effect
A Ingredient FitD+ PathwaysB+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

CoQ10 in the ubiquinone form has limited support for fatigue relief, distinct from an immediate alertness effect. Its role in cellular energy production does not by itself prove a noticeable energy boost, and clinical disease findings do not transfer to routine healthy use. The declared amount meets the saved comparison fully, without establishing an optimal dose.

How this product is rated for Energy

Ingredient fit93

Coenzyme Q-10 anchors the recognized ingredient fit, with declared amounts fully meeting the saved comparisons.
Goal fit
Coenzyme Q-10 is central to the product’s recognized energy connection, although the product is also linked to other goals.
Dose adequacy
The declared amounts fully meet the saved comparisons; these are not proven fatigue-treatment doses.

Pathways53

The saved coverage is concentrated in mitochondrial energy production.
Depth
The strongest saved coverage concerns mitochondrial energy production; this does not independently prove a noticeable energy benefit.
Breadth
Coverage reaches the saved threshold for mitochondrial energy production, with no comparable breadth across other energy pathways.

Evidence84

Coenzyme Q-10 leads the recognized evidence, but the supplied context limits how broadly its findings apply.
Evidence strength
Coenzyme Q-10 supplies the strongest recognized evidence here, subject to the population and application limits described for it.
Studied preparation
The saved findings accept the qualifying preparations; this does not establish form superiority.

Formulation logic100

No required partner is missing, and no configured sedative conflict is present. The recognized amounts reach the saved minimum comparison.
Partner coverage
The recognized ingredients have no missing required partner for their assigned contributions.
Conflicts
No configured sedative conflict applies: valerian, kava, qualifying tryptophan and melatonin are absent.
Effective doses
All recognized ingredients reach the saved minimum amount comparison; that threshold is not proof of a clinical energy effect.
Study evidence
Heart Health
Impact
High effect
B Ingredient FitD PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

Coenzyme Q10, declared as ubiquinone, has limited support from small human studies of vascular, blood-pressure or lipid measurements. The saved findings place its contribution in endothelial function, rather than demonstrating prevention of cardiovascular events. The 400 mg serving only partly meets this preparation's saved comparison; that finding does not mean measured loss of efficacy at higher exposure. Piperine does not establish an added heart-health benefit or a superior CoQ10 response.

How this product is rated for Heart Health

Ingredient fit80

Declared conventional CoQ10 provides a focused preparation-specific contribution with a partial exposure comparison.
Goal fit
CoQ10 provides the credited contribution, with piperine treated as a companion.
Dose adequacy
The 400 mg serving partly meets its preparation comparison; the saved above-anchor reduction is not measured loss of efficacy.

Pathways47

Endothelial nitric-oxide function is the strongest assigned area. Only endothelial function reaches substantial coverage.
Depth
Endothelial nitric-oxide function has the strongest saved coverage; that assignment does not establish prevention of cardiovascular events.
Breadth
Only endothelial function reaches substantial coverage.

Evidence98

CoQ10 leads the saved support finding, limited to small selected-population vascular or blood-pressure studies.
Evidence strength
Coenzyme Q10 leads the saved evidence finding, within the preparation, population and outcome limits of the supplied context.
Studied preparation
Credited preparations meet the saved criteria; this does not extend selected-population or surrogate findings to general event prevention.

Formulation logic100

Credited ingredients clear the saved amount threshold and have no assessed missing partner or conflict.
Partner coverage
Credited ingredients work alone or have their relevant partners; no additional combination benefit follows from this finding.
Conflicts
No assessed ingredient conflict was triggered.
Effective doses
All credited ingredients clear the saved minimum amount threshold, which is not proof of cardiovascular benefit.
Study evidence
Longevity
Impact
Moderate effect
A Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

CoQ10 at 400 mg supplies a mitochondrial energy and antioxidant ingredient. Piperine may help absorption, while the supplied skin-aging findings remain preparation specific and higher amounts do not imply greater longevity benefits.

How this product is rated for Longevity

Ingredient fit93

The relevant ingredients give the formula a aging-relateded connection to this goal. The amounts assessed meet the saved comparison levels.
Goal fit
The relevant ingredients give the formula a aging-relateded connection to this goal.
Dose adequacy
The amounts assessed meet the saved comparison levels.

Pathways40

The strongest connection is mitochondrial energy production, with moderate coverage. One direct aging-related mechanism reaches the saved coverage threshold.
Depth
The strongest connection is mitochondrial energy production, with moderate coverage.
Breadth
One direct aging-related mechanism reaches the saved coverage threshold.

Evidence30

Coenzyme Q-10 provides the strongest evidence connection among ingredients counted at relevant amounts, with limited scope for everyday aging-related benefits. The materials assessed are not matched to preparations used in the supplied aging-related trials.
Evidence strength
Coenzyme Q-10 provides the strongest evidence connection among ingredients counted at relevant amounts, with limited scope for everyday aging-related benefits.
Studied preparation
The materials assessed are not matched to preparations used in the supplied aging-related trials.

Formulation logic100

The assessed ingredients can work alone or have their relevant partner present. No ingredient conflict was found in the supplied checks. All ingredients counted in this check meet its minimum amount threshold.
Partner coverage
The assessed ingredients can work alone or have their relevant partner present.
Conflicts
No ingredient conflict was found in the supplied checks.
Effective doses
All ingredients counted in this check meet its minimum amount threshold.
Study evidence
Cardiovascular Support
Impact
Highest effect
A Ingredient FitC PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

Coenzyme Q10 provides the main cardiovascular connection through limited support for blood-vessel function and blood-pressure or lipid markers. The declared ubiquinone amount is substantial in the saved findings. The supporting studies involved people with abnormal lipids or vessel function, so broad benefits in healthy adults remain uncertain. A higher amount does not establish greater benefit or prevention of cardiovascular events.

How this product is rated for Cardiovascular Support

Ingredient fit93

Coenzyme Q-10 gives the formula a clear connection to cardiovascular support. The relevant declared amounts reach the saved comparison reference; that reference does not predict the size of a benefit.
Goal fit
Coenzyme Q-10 gives the formula a clear connection to cardiovascular support.
Dose adequacy
The relevant declared amounts reach the saved comparison reference; that reference does not predict the size of a benefit.

Pathways60

The strongest saved connection is endothelial nitric-oxide function. One aspect reaches substantial coverage; support across other aspects is limited or absent.
Depth
The strongest saved connection is endothelial nitric-oxide function.
Breadth
One aspect reaches substantial coverage; support across other aspects is limited or absent.

Evidence88

The supplied studies support specific marker or nutrient roles, with the limitations described for the relevant ingredients.
Evidence strength
Coenzyme Q-10 provides the strongest amount-qualified evidence connection, subject to its population and outcome limitations.
Studied preparation
The preparations that qualify by amount match those accepted in the supplied evidence; this does not establish superiority over other forms.

Formulation logic100

The contributing ingredients work independently or have the partners required by the supplied findings. No listed formulation conflict was identified in the supplied facts.
Partner coverage
The contributing ingredients work independently or have the partners required by the supplied findings.
Conflicts
No listed formulation conflict was identified in the supplied facts.
Effective doses
All contributing ingredients meet the saved minimum amount check; this is not a guarantee of clinical benefit.
Study evidence
Metabolism Support
Impact
High effect
A Ingredient FitD+ PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

Coenzyme Q10 participates in mitochondrial electron transport, helping cells carry out normal energy production. That role and changes in metabolic biomarkers do not establish that supplementation raises whole-body calorie expenditure. The declared amount is therefore a nutritional or mechanistic connection, without a demonstrated routine metabolism boost or preference for a particular form.

How this product is rated for Metabolism Support

Ingredient fit93

Coenzyme Q-10 provide the main connection. The included amounts meet the reference comparisons, but these are not proven thermogenic or weight-loss doses.
Goal fit
Coenzyme Q-10 provide the main metabolic connection, with little diversion to other ingredients.
Dose adequacy
The included amounts meet the reference comparisons, but these are not proven thermogenic or weight-loss doses.

Pathways54

The main connection concerns mitochondrial energy processes, which are not proof of increased whole-body calorie expenditure. The main coverage is concentrated in one area, rather than broad evidence for increased calorie expenditure.
Depth
The main connection concerns mitochondrial energy processes, which are not proof of increased whole-body calorie expenditure.
Breadth
The main coverage is concentrated in one area, rather than broad evidence for increased calorie expenditure.

Evidence75

CoQ10’s mitochondrial role and metabolic-marker findings do not establish a routine increase in whole-body energy expenditure.
Evidence strength
CoQ10’s mitochondrial role and metabolic-marker findings do not establish a routine increase in whole-body energy expenditure.
Studied preparation
The included preparations match the saved comparison, which does not establish a measured increase in energy expenditure.

Formulation logic100

No missing required partner or configured conflict was identified. The included amounts meet the minimum exposure comparison without demonstrating an extra benefit from combining them.
Partner coverage
No missing required partner was identified; the combination does not establish an additional metabolic-rate effect.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
The included ingredients meet the minimum exposure comparison, which does not establish an effective thermogenic or weight-loss dose.
Study evidence
Inflammation
Impact
Highest effect
A- Ingredient FitD+ PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

CoQ10 in the ubiquinone form has limited evidence for lowering one inflammatory marker in statin-treated people with coronary artery disease. Other measured markers were unchanged, so this does not establish a broad clinical anti-inflammatory effect in general users. The 400 mg per serving is above the reviewed 300 mg daily exposure, without establishing greater benefit.

How this product is rated for Inflammation

Ingredient fit86

Coenzyme Q-10 anchors the fit, with amount or preparation limits reducing the attributable contribution.
Goal fit
The declared ingredients are concentrated on the inflammation-related roles considered here.
Dose adequacy
The CoQ10 amount exceeds the reviewed study exposure, so a larger contribution is not assumed.

Pathways52

The represented contribution centres on oxidative and mitochondrial stress. Other specified routes have limited coverage.
Depth
Oxidative and mitochondrial stress is the strongest represented route, with ingredient-specific limits on the expected clinical effect.
Breadth
One specified route reaches the required coverage, with little breadth across the others.

Evidence93

Coenzyme Q-10 provides the strongest included finding. Biomarker or selected-population findings do not establish broad clinical benefit.
Evidence strength
Coenzyme Q-10 anchors the evidence finding, with the described population and biomarker limitations still applying.
Studied preparation
The included preparations satisfy the supplied comparison, without removing their population or outcome limitations.

Formulation logic100

The included ingredients meet the amount and partner checks, with no specified conflict triggered.
Partner coverage
No required supporting partner is missing for the included ingredients.
Conflicts
None of the specified ingredient conflict checks was triggered.
Effective doses
The included ingredients meet the minimum amount comparison; it is not a proven clinical anti-inflammatory dose.
Study evidence

Ingredients

IngredientAmount per servingScore
Coenzyme Q10 (Ubiquinone)
400 mg 81
Black Pepper ext. (Piperine)
5 mg
Gluten Free Adults 18–50 Vegan Vegetarian
Report overview
C Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyA+ Value
Each serving supplies 400 mg of CoQ10 as ubiquinone and includes BioPerine. The CoQ10 costs about $0.11 per 100 mg, a comparatively low price for this form.
How this ingredient is rated

Active Ingredient Quality & Bioavailability64

CoQ10 is ubiquinone and BioPerine is present as an absorption enhancer.
Molecular Form: Ubiquinol vs. Ubiquinone
The CoQ10 is ubiquinone, a form the body converts to ubiquinol.
Formulation & Absorption Enhancers
BioPerine is present as an absorption enhancer; its amount and effect on absorption are not established here.

Dose, Safety & Label Transparency88

The serving provides 400 mg of ubiquinone. A standard filler is also identified.
Clinical Dosage Alignment
The 400 mg of ubiquinone per serving aligns well with the evaluation.
Label Transparency & Fillers
The amount is stated, and the evaluation identifies a standard filler.

Value100

CoQ10 costs about $0.11 per 100 mg, a comparatively low price for ubiquinone.
Price Per Effective Serving
CoQ10 costs about $0.11 per 100 mg, a comparatively low price for ubiquinone.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  7. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  8. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  9. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  10. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  11. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  12. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  13. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  14. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  15. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10
  16. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
    Karamali M; Gholizadeh M · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2022
    Randomized trial55 participantsInflammation forCoenzyme Q-10
  17. Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
    Hou S; Tian Z; Zhao D; Liang Y; Dai S; Ji Q; Fan Z; Liu Z; Liu M; Yang Y · Molecular nutrition & food research · 2023
    Meta-analysis1,517 participants31 studies pooledInflammation forCoenzyme Q-10
  18. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M · Pharmacological research · 2020
    Meta-analysis509 participants9 studies pooledInflammation forCoenzyme Q-10
  19. Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
    Elsherif N; Shousha G; Sabri NA; Shawki MA · Immunopharmacology and immunotoxicology · 2026
    Randomized trial58 participantsInflammation forCoenzyme Q-10
  20. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.
    Mantle D; Hargreaves I · Antioxidants (Basel, Switzerland) · 2020
    Narrative reviewLongevity forCoenzyme Q-10